UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

In recent weeks, UiPath announced new agentic AI solutions for healthcare revenue cycle management, achieved the AIUC-1 certification for secure enterprise AI agents, and prepared to report quarterly ...

UiPath develops enterprise automation technology platforms; Robotic process automation enables digital workflow transformation; UiPath software integrates artificial i ...

UiPath PATH shares are trading higher on Wednesday. The company recently achieved AIUC 1 certification, setting a new standard for AI agent security and reliability. • How is PATH stock doing now?

UiPath (NYSE: PATH), a leader in agentic automation, announced today the Company has rescheduled its fourth quarter and year-end earnings Q&A session to March 11, 2026 at 6:45 p.m ...

UiPath (NYSE: PATH) isn't just an automation company anymore. It's quietly transforming into a key infrastructure player at the intersection of automation, data, and artificial intelligence (AI). To ...

Breaks down the barriers to enterprise AI adoption by enhancing security and compliance, improving accuracy and reliability, overcoming stalled pilot projects, and avoiding vendor lock-in Blends ...

UiPath Inc. reports fiscal fourth-quarter results Wednesday after market close, with investors scrutinizing whether the automation software maker’s pivot to artificial intelligence-powered "agentic ...

Automation software company UiPath (NYSE:PATH) will be reporting results this Wednesday after market close. Here’s what you need to know. UiPath beat analysts’ revenue expectations last quarter, ...

C3.ai, Inc. AI and UiPath Inc. PATH are both high-profile players in the booming AI automation sector. C3.ai specializes in enterprise AI applications, including predictive maintenance and generative ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

Gupta provided fiscal year 2027 guidance, stating, "For the full fiscal year 2027, we expect revenue in the range of $1.754 billion to $1.759 billion, ARR in the range of $2.051 billion to $2.056 ...